A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells are reprogrammed ...

A man with Parkinson's disease has been treated with a transplant of his own brain cells, doctors revealed yesterday. Cells were removed from his brain, nurtured in the laboratory then reinjected.

Parkinson’s Disease - Medical world has struggled in finding permanent cure for this condition that usually affects men over the age of 50 years, but now this maybe changing with the advent of ...

In Parkinson's disease, a protein called alpha-synuclein misfolds and clumps together. Those clumps then damage dopamine-producing nerve cells in the brain, which leads to the typical Parkinson's ...

What if your brain could be repaired by your own cells? Researchers at Mass General Brigham are developing the first-ever personalized stem cell therapy for Parkinson's disease. Rather than merely ...

It's a case of so far, so good for BlueRock Therapeutics' first clinical trial of Parkinson's disease therapy bemdaneprocel, with no major safety issues reported after a year in patients who ...

A recently launched Phase 1 clinical trial at Mass General Brigham is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem ...

LA JOLLA, CA—Scientists at La Jolla Institute for Immunology (LJI) have found a potential new target for treating Parkinson's disease. Their new research reveals how a protein in brain cells may ...

More information: Safe CNV removal is crucial for successful hESC-RPE transplantation in wet age-related macular degeneration, Stem Cell Reports (2025).

A recently launched Phase 1 clinical trial at Mass General Brigham is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson’s disease in which a patient’s stem ...

A recently launched Phase 1 clinical trial at Mass General Brigham is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson’s disease in which a patient’s ...